ZA971964B - Azolobenzazepine derivatives and compositions and method of use thereof. - Google Patents
Azolobenzazepine derivatives and compositions and method of use thereof.Info
- Publication number
- ZA971964B ZA971964B ZA9701964A ZA971964A ZA971964B ZA 971964 B ZA971964 B ZA 971964B ZA 9701964 A ZA9701964 A ZA 9701964A ZA 971964 A ZA971964 A ZA 971964A ZA 971964 B ZA971964 B ZA 971964B
- Authority
- ZA
- South Africa
- Prior art keywords
- azolobenzazepine
- derivatives
- compositions
- azolobenzazepine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1352896P | 1996-03-08 | 1996-03-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA971964B true ZA971964B (en) | 1997-09-08 |
Family
ID=21760422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9701964A ZA971964B (en) | 1996-03-08 | 1997-03-06 | Azolobenzazepine derivatives and compositions and method of use thereof. |
Country Status (13)
Country | Link |
---|---|
US (2) | US6124281A (xx) |
EP (1) | EP0888350A1 (xx) |
JP (1) | JP2000506160A (xx) |
KR (1) | KR19990087585A (xx) |
CN (1) | CN1084747C (xx) |
AU (1) | AU723860B2 (xx) |
CA (1) | CA2247453A1 (xx) |
IL (1) | IL126095A0 (xx) |
NO (1) | NO984106L (xx) |
NZ (1) | NZ330973A (xx) |
TW (1) | TW486480B (xx) |
WO (1) | WO1997032883A1 (xx) |
ZA (1) | ZA971964B (xx) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE233764T1 (de) * | 1997-09-29 | 2003-03-15 | Meiji Seika Kaisha | Tricyclische triazolobenzazepinderivate, verfahren zu ihrer herstellung und antiallergische mittel |
US7919109B2 (en) * | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
AU2002367110A1 (en) * | 2001-12-26 | 2003-07-15 | Meiji Seika Kaisha, Ltd. | Amorphous substance of tricyclic triazolobenzazepine derivative |
JP2005525333A (ja) * | 2002-02-07 | 2005-08-25 | ニューロジェン コーポレイション | 置換縮合ピラゾールカルボン酸アリールアミド及び関連化合物 |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
MXPA06013042A (es) | 2004-05-14 | 2007-02-12 | Millennium Pharm Inc | Compuestos y m??todos para inhibir la progresion mit??tica. |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
ES2351527T3 (es) | 2006-05-30 | 2011-02-07 | Intarcia Therapeutics, Inc | Modulador de flujo en dos piezas con conducto interno para un sistema osmótico de administración. |
NZ574524A (en) | 2006-08-09 | 2011-07-29 | Intarcia Therapeutics Inc | Piston assembly for positioning lumen of a reservoir for an osmotic delivery having a columnar body and a spring |
CL2007003244A1 (es) | 2006-11-16 | 2008-04-04 | Millennium Pharm Inc | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. |
EP2157967B1 (en) | 2007-04-23 | 2013-01-16 | Intarcia Therapeutics, Inc | Suspension formulations of insulinotropic peptides and uses thereof |
WO2009102467A2 (en) | 2008-02-13 | 2009-08-20 | Intarcia Therapeutics, Inc. | Devices, formulations, and methods for delivery of multiple beneficial agents |
JP5738196B2 (ja) | 2008-12-22 | 2015-06-17 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | オーロラキナーゼ阻害剤および抗cd20抗体の併用 |
JO3635B1 (ar) | 2009-05-18 | 2020-08-27 | Millennium Pharm Inc | مركبات صيدلانية صلبة وطرق لانتاجها |
LT2462246T (lt) | 2009-09-28 | 2017-11-27 | Intarcia Therapeutics, Inc | Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas |
CN102770024A (zh) | 2010-02-19 | 2012-11-07 | 米伦纽姆医药公司 | 4-{[9-氯-7-(2-氟-6-甲氧基苯基)-5h-嘧啶并[5,4-d][2]苯并氮杂卓-2基]氨基}-2-甲氧基苯甲酸钠的结晶形式 |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US20130303519A1 (en) | 2012-03-20 | 2013-11-14 | Millennium Pharmaceuticals, Inc. | Methods of treating cancer using aurora kinase inhibitors |
WO2014153509A1 (en) | 2013-03-22 | 2014-09-25 | Millennium Pharmaceuticals, Inc. | Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
JP6993235B2 (ja) | 2015-06-03 | 2022-01-13 | インターシア セラピューティクス,インコーポレイティド | インプラントの設置及び撤去システム |
EP3458084B1 (en) | 2016-05-16 | 2020-04-01 | Intarcia Therapeutics, Inc | Glucagon-receptor selective polypeptides and methods of use thereof |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
KR20190104039A (ko) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9311948D0 (en) * | 1993-06-10 | 1993-07-28 | Zeneca Ltd | Substituted nitrogen heterocycles |
WO1995018130A1 (fr) * | 1993-12-28 | 1995-07-06 | Meiji Seika Kabushiki Kaisha | Derives tricycliques de benzazepine et benzothiazepine |
US6093714A (en) * | 1995-06-15 | 2000-07-25 | Meiji Seika Kaisha, Ltd. | Tricyclic benzazepine compounds |
-
1997
- 1997-03-04 IL IL12609597A patent/IL126095A0/xx unknown
- 1997-03-04 TW TW086102601A patent/TW486480B/zh active
- 1997-03-04 CA CA002247453A patent/CA2247453A1/en not_active Abandoned
- 1997-03-04 JP JP9531562A patent/JP2000506160A/ja not_active Ceased
- 1997-03-04 WO PCT/GB1997/000592 patent/WO1997032883A1/en not_active Application Discontinuation
- 1997-03-04 NZ NZ330973A patent/NZ330973A/xx unknown
- 1997-03-04 CN CN97192864A patent/CN1084747C/zh not_active Expired - Fee Related
- 1997-03-04 EP EP97905327A patent/EP0888350A1/en not_active Withdrawn
- 1997-03-04 KR KR1019980707026A patent/KR19990087585A/ko not_active Application Discontinuation
- 1997-03-04 US US09/142,221 patent/US6124281A/en not_active Expired - Fee Related
- 1997-03-04 AU AU22253/97A patent/AU723860B2/en not_active Ceased
- 1997-03-06 ZA ZA9701964A patent/ZA971964B/xx unknown
-
1998
- 1998-09-07 NO NO984106A patent/NO984106L/no not_active Application Discontinuation
-
2000
- 2000-09-22 US US09/668,261 patent/US6313290B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1084747C (zh) | 2002-05-15 |
NZ330973A (en) | 2000-03-27 |
US6124281A (en) | 2000-09-26 |
TW486480B (en) | 2002-05-11 |
AU2225397A (en) | 1997-09-22 |
EP0888350A1 (en) | 1999-01-07 |
WO1997032883A1 (en) | 1997-09-12 |
CA2247453A1 (en) | 1997-09-12 |
JP2000506160A (ja) | 2000-05-23 |
AU723860B2 (en) | 2000-09-07 |
US6313290B1 (en) | 2001-11-06 |
NO984106L (no) | 1998-11-06 |
NO984106D0 (no) | 1998-09-07 |
CN1224424A (zh) | 1999-07-28 |
IL126095A0 (en) | 1999-05-09 |
KR19990087585A (ko) | 1999-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA971964B (en) | Azolobenzazepine derivatives and compositions and method of use thereof. | |
GB9616411D0 (en) | Shampoo compositions and method | |
GB9422571D0 (en) | Haemorrihoidal compositions and method of use | |
GB2319250B (en) | Derivatives of 6,8-Difluoro-7-Hydroxycoumarin | |
HUP0101172A3 (en) | Ortho-anthranilamide derivatives and their use as anti-coagulants | |
PL331900A1 (en) | 1,4-heterocyclic inhibitors of metaloprotease | |
PL329875A1 (en) | Derivatives of carbolin | |
HK1112180A1 (en) | Pharmaceutical use and compositions involving isoflavones | |
PL331838A1 (en) | 1,3-diheterocyclic inhibitors of metaloproteases | |
HK1034906A1 (en) | Method and composition of an oral preparation of itraconazole. | |
ZA989399B (en) | Method and composition | |
PH31270A (en) | Superplasticizer-concrete composition and method of preparation. | |
GB2346823B (en) | Reamer and method of using the same | |
GB9624501D0 (en) | Insecticial compositions and method | |
EP0801648A4 (en) | SUBSTITUTED DERIVATIVES OF 2-ARYLCARBONYLOXYMETHYL-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE, COMPOSITIONS CONTAINING THEM AND METHODS OF USE | |
IL128614A0 (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
AU1841195A (en) | 1-beta -methyl-carbapenem, compositions containing same and methods of use | |
EP1139981A4 (en) | COMPOSITIONS AND RELATED METHODS OF USE | |
AU3200197A (en) | New composition and methods | |
GB9420616D0 (en) | Method, compositions and use | |
GB2318356B (en) | Composition and method | |
IL120488A (en) | Modifiers for water-setting inorganic compositions and modified water-setting inorganic compositions | |
PL319070A1 (en) | Derivatives of 1,25-dihydroxy-16,22,23-trisdehyrochoecalcifero, method of obtaining them and compositions containing such derivatives | |
GB9419087D0 (en) | Method and composition | |
GB9414888D0 (en) | Method and composition |